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Mitogen-induced initiation of DNA synthesis in quiescent Chinese hamster lung fibroblasts (CCL39) is strongly inhibited 
by 8-Br CAMP and CAMP-elevating agents (prostaglandin E,, cholera toxin, isobutylmethylxanthine). This inhibition 
is reversible and occurs very early in G,,/G, . As exponential growth is much less affected by increased CAMP, we propose 
that CAMP inhibits an early signal essential for the exit from G,,. CCL39 cells can be stimulated by a-thrombin, which 
activates phosphoinositide (PI) breakdown, as well as by mitogens (FGF or FGF+serotonin) which do not involve the 
PI pathway. Here we show that the action of both classes of mitogens is likewise inhibited by CAMP. Therefore, although 
PI breakdown is inhibited by CAMP in CCL39 cells, this effect cannot entirely account for the antimitogenic activity 
of CAMP. Other early steps of the mitogenic response must be also affected. 
DNA synthesis; cyclic AMP; Growth factor; (Hamster fibroblast) 
1. INTRODUCTION 
The role of CAMP in growth control has been 
the subject of a large and controversial iterature. 
While elevation of intracellular CAMP has been 
found to cause growth inhibition in a wide variety 
of cell types [l], it appears on the contrary to act 
as a mitogenic signal in some cells such as Swiss 
3T3 cells 121. The reasons for these discrepancies 
are still largely unknown, but one possibility is that 
the sensitivity to CAMP of the mitogenic signalling 
pathways varies from tissue to tissue. We have 
recently proposed that growth factors can be divid- 
ed into two classes which act through distinct 
signal-transduction pathways [3]. Receptors for 
the first class possess a tyrosine kinase activity [4], 
whereas receptors for the second are coupled 
through GTP-binding proteins to various effecters 
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including a phosphoinositide-specific phospho- 
lipase C [5]. Most interestingly, phosphoinositide 
hydrolysis is inhibited by CAMP in some cell types 
[6-91 but not in others [g-12]. Here, we have 
therefore addressed the question of a possible cor- 
relation between the inhibitory effects of CAMP on 
phosphoinositide breakdown and reinitiation of 
DNA synthesis, using a Chinese hamster lung 
fibroblast line (CCL39), which responds to either 
class of mitogens. DNA synthesis can be induced 
in these cells by thrombin [13], with stimulation of 
inositol lipid metabolism [14] or by FGF without 
any significant phosphoinositide hydrolysis [ 151. 
Here we show that CAMP, which inhibits 
thrombin-induced inositol phosphate formation 
[6,16], strongly inhibits the mitogenic response to 
thrombin but also that to FGF, which indicates 
that the inhibitory activity of CAMP is not 
restricted to the inositol pathway. 
2. MATERIALS AND METHODS 
2.1. Materials 
Highly purified cu-thrombin (2660 NIH units/mg) was 
generously provided by Dr J.W. Fenton ii (New York State 
Department of Health, Albany, NY). Recombinant basic FGF 
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was a gift from Dr D. Gospodarowicz (University of California, 
Medical Center, San Francisco, CA). Prostaglandin Et (PGEt), 
cholera toxin and serotonin were from Sigma. 8-Br CAMP was 
purchased from Boehringer Mannheim. [3H]Thymidine was 
from Amersham. 
2.2. Cell culture 
The Chinese hamster lung fibroblast line (CCL39) was main- 
tained in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) 
supplemented with 10% (v/v) fetal calf serum, antibiotics (50 U 
penicillin/ml and 5Opg streptomycin/ml) in a humidified at- 
mosphere of 5% COs/95% air. 
2.3. DNA synthesis 
Cells grown to confluence in 24well culture plates were ar- 
rested in GO by 24 h incubation in serum-free medium (1: 1 ratio 
of DMEM:Ham’s F-12). Cells were then incubated with the 
mitogens and the different agents to be tested as indicated in the 
figure legends. Reinitiation of DNA synthesis was determined 
either by [‘Hlthymidine (1 &i/ml, 4.5 FM) accumulation over 
24 h, or [‘Hlthymidine (2 &i/ml) incorporation during a 2 h 
pulse at different time points in the cell cycle. At the end of the 
incubation period, radioactivity in trichloroacetic acid- 
precipitable material was determined after solubilization of the 
cells in 0.1 N NaOH. 
2.4. Cell growth assay 
Cells were plated at an initial density of 2 x lO=’ cells per 
35-mm culture dish in 2 ml DMEM plus 10% FCS. After 24 h 
incubation to allow for cell attachment, he medium was chang- 
ed to DMEM plus 10% FCS and various agents as described in 
the figure legends. For determination of cell number, cells were 
removed from the wells with trypsin and counted in a Coulter 
counter. 
3. RESULTS 
Reinitiation of DNA synthesis can be induced in 
quiescent CCL39 cells by either thrombin [13] or 
FGF alone [ 151, or more efficiently by combina- 
tions of FGF and thrombin [17] or FGF and 
serotonin [ 181. Fig. 1 shows that whatever the 
mitogen or the combination of mitogens used, 
DNA synthesis is strongly inhibited by elevation of 
intracellular CAMP. A dose-dependent decrease in 
[3H]thymidine incorporation was caused by activa- 
tion of adenylate cyclase, whether receptor- 
mediated with PGEi (fig.lA) or nonreceptor- 
mediated with cholera toxin (fig. lB), as well as by 
addition of the CAMP derivative 8-Br CAMP 
(fig.lC). Half-maximal inhibition was observed 
around 3 x lo-* M PGEi, 0.2 ng/ml cholera toxin 
and 0.1-0.2 mM 8-Br CAMP. The response to 
FGF was completely abolished by the three in- 
hibitors, whereas thrombin-induced DNA syn- 
thesis appeared slightly less sensitive to PGEi and 
cholera toxin, with maximal inhibition of 75 and 
60%, respectively. Initiation of DNA synthesis in 
CCL39 cells was also strongly inhibited by IBMX, 
an inhibitor of cyclic nucleotide phosphodi- 
esterase, with an ICSO of about 0.1 mM (not 
shown). 
To determine at which stage of the cell cycle 
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Fig. 1. Inhibition of mitogen-induced DNA synthesis in CCL39 cells by PGEt , cholera toxin or 8-Br CAMP. Go-arrested CCL39 cells 
were incubated for 24 h with [“Hlthymidine (1 &i/ml) in the absence (q ) or presence of various mitogens: 1 U/ml thrombin (0) or 
20 ng/ml FGF (A) in A; 0.1 U/ml thrombin (0), 20 ng/ml FGF (A) or 0.1 U/ml thrombin + 20 ng/ml FGF (0) in B; 1 U/ml 
thrombin (o), 20 ng/ml FGF (A) or 20 ng/ml FGF + 1 CM serotonin (A) in C. PGEt (A), cholera toxin (B) or 8-Br CAMP (C) were 
added together with the mitogens at the indicated concentrations. Results are means of duplicate determinations. 
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Fig.2. Time-dependent inhibition by CAMP of mitogen-induced 
DNA synthesis in CCL39 cells. Go-arrested cells were incubated 
at time 0 with [“HJthymidine (1 &i/ml) and 20 ng/ml FGF + 
lo--’ U/ml thrombin. At the times indicated, cultures received 
either 1 CM PGEr (0) or 0.1 mM IBMX (0) and 
[‘Hlthymidine incorporation was measured 24 h after growth 
factor addition. Bars represent [3H]thymidine incorporation in 
the absence of inhibitor, in unstimulated control cells (C) or in 
stimulated cells (FGF + THR). 
THROMBIN 
CAMP exerts its inhibitory effect, CAMP-elevating 
agents were added at various times after the 
mitogens. Fig.2 shows that the inhibition of DNA 
synthesis was progressively attenuated when the 
additions of PGEi or IBMX were delayed, with a 
50% reduction after 13 h, regardless of the degree 
of the maximal inhibition (PGEr was used at a 
maximally inhibitory concentration whereas 
IBMX was used at an I(&). Similar data were ob- 
tained with FGF alone (not shown). These results 
clearly indicate that the inhibitory activity of 
CAMP occurs very early in the Go/G1 phase of the 
cell cycle, irrespective of the mitogens used. 
The reversibility of CAMP inhibition was in- 
vestigated in fig.3. PGEi was chosen to induce a 
transient elevation of CAMP, because this com- 
pound can be readily washed out, as checked by 
the return of adenylate cyclase activity to basal 
level (not shown). After 4 h exposure to 1 PM 
PGEi, thrombin- or FGF-stimulated CCL39 cells 
entered the S phase but with a marked delay, which 
at least in thrombin-stimulated cells roughly cor- 
responded to the length of PGEi treatment. Thus, 
elevation of CAMP at the moment of mitogen ad- 
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Fig.3. Effect of short exposure to PGEr on thrombin- and FGF-induced DNA synthesis in CCL39 cells. Go-arrested cells were 
incubated at time 0 with (0, A) or without (0, A , 0) 1 FM PGEr in the presence of 1 U/ml thrombin (o,o), 20 ng/ml FGF (A , i) 
or without growth factor (0). After 4 h the medium was removed and cultures were washed four times to eliminate PGEr (control 
cultures without PGEr were treated in the same way). Then mitogens were added back in fresh medium and incubations continued. 
The incorporation of [3H]thymidine (2 &i/ml) was monitored at 2-h intervals from 16 to 24 h after the stimulation by mitogens. 
Values are plotted at the times corresponding to the middle of the pulses and represent means + range of duplicate determinations. 
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dition appears to block reversibly cells at a point in serum-induced DNA synthesis in Go-arrested cells, 
GO or early Gi. did not affect growth of cycling cells (not shown). 
To determine whether exponentially growing 
cells are as sensitive to CAMP as Go-arrested cells, 
serum-induced proliferation was measured in the 
presence of 1 PM PGEi or 1 mM 8-Br CAMP 
(fig.4). Clearly cell growth was much less affected 
by CAMP than reinitiation of DNA synthesis in 
quiescent cells, since 1 PM PGEi did not change 
the growth rate whereas it reduced serum-induced 
DNA synthesis by 60% in quiescent cells (fig.4, in- 
set). Significant inhibition of growth (by about 
50%) was caused by 1 mM 8-Br CAMP but it 
should be noted that this concentration inhibited 
the reinitiation of DNA synthesis by -90% in 
quiescent cells (fig.4, inset). A lower concentration 
(0.2 mM), which gave half-maximal inhibition of 
4. DISCUSSION 
We report here that reinitiation of DNA syn- 
thesis by mitogens in Go-arrested CCL39 cells is 
strongly inhibited by elevation of intracellular 
CAMP, irrespective of the method used to increase 
CAMP. Similar results were obtained with PGEi, 
cholera toxin, IBMX and 8-Br CAMP. The inhibi- 
tion is reversible, since it is suppressed by wash-out 
of CAMP-elevating agents, and it occurs at a very 
early stage in the progression from Go to S phase. 
This observation is in agreement with studies in 
other cell types [ 1,19,20] but in contrast with other 
reports describing an inhibitory effect of CAMP in 
late Gi [21,22]. Proliferation of CCL39 cells in the 
presence of 10% fetal calf serum is markedly less 
sensitive to elevated CAMP. This is not due to the 
presence in serum of growth factors which allow 
the cells to by-pass the CAMP-sensitive step, 
because serum-induced reinitiation of DNA syn- 
thesis in Go-arrested cells was inhibited by PGEr 
and 8-Br CAMP to an extent very similar to that in 
thrombin-stimulated cells (figs 1,4, inset). 
Moreover, the restimulation by serum of 
Go-arrested cells was similarly inhibited by CAMP 
in confluent and subconfluent cultures (not 
shown), which indicates that high cellular density 
is not required for CAMP-induced inhibition, in 
contrast with findings in human fibroblasts [23]. 
Thus, taken together, our data support the conten- 
tion that in CCL39 cells increased CAMP primarily 
affects a mitogenic signal which is essential for the 
exit of resting cells from Go but less important for 
logarithmically growing cells. 
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Fig.4. Effect of PGEt and 8-Br CAMP on growth of CCL39 
cells. Cells were plated as indicated in the text and at the time 
indicated by the arrow received fresh medium containing 10% 
FCS with 1 PM PGEt (o), 1 mM 8-Br CAMP (A) or no 
addition (0). Medium was replaced daily and cell number was 
determined at the times indicated. (Inset) Go-arrested cells were 
incubated for 24 h with [3H]thymidine (1 &i/ml) and 10% 
FCS (first bar), 10% FCS + 1 PM PGEt (second bar) or 10% 
FCS + 1 mM 8-Br CAMP (third bar). Results are means of 
triplicate determinations and are expressed relative to 
[‘Hlthymidine incorporation in control cells (100% = 2 x 
lo5 dpm/well). 
However, the most important finding of this 
study is that CAMP inhibits the mitogenic response 
to all of the growth-promoting agents for CCL39 
cells, irrespective of the signalling pathway ac- 
tivated. Whereas phosphoinositide hydrolysis is 
believed to play an important role in the mitogenic 
activity of thrombin [ 171, it has been shown that 
this pathway is not involved in FGF-induced 
mitogenesis [15] or in the potentiating effect of 
serotonin on FGF-induced DNA synthesis [ 181. 
Since CAMP inhibits the mitogenic response of 
CCL39 cells to FGF alone or to FGF + serotonin 
as well as the response to thrombin, it is clear that 
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CAMP-mediated inhibition of Gr progression is 
not solely caused by inhibition of the inositol lipid 
pathway that CAMP-elevating agents elicit in 
CCL39 cells [6,16]. Therefore, our results suggest 
that increased CAMP inhibits, presumably through 
activation of protein kinase A [24], other early 
steps of the mitogenic response, in addition to 
phosphoinositide hydrolysis. These putative sites 
of inhibition may be located either on the tyrosine 
kinase-activated signalling pathway, or more 
downstream of phospholipase C and tyrosine 
kinases, on some step common to both pathways. 
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